Accession Number: | 0001415889-23-002169 |
Date: | 2023-02-06 |
Issuer: | AEROVATE THERAPEUTICS, INC. (AVTE) |
Original Submission Date: |
NIVEN RALPH
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM, MA 02451
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-02-06 | M | 650 | a | $1.74 | 2,259 | direct | ||
COMMON STOCK | 2023-02-06 | M | 1,600 | a | $2.14 | 3,859 | direct | ||
COMMON STOCK | 2023-02-06 | S | 2,250 | d | $24.27 | 1,609 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.74 | 2023-02-06 | deemed execution date | M | 450 (d) | 2030-09-03 | common stock 450 | $1.74 | 20,958 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 1.74 | 2023-02-06 | deemed execution date | M | 200 (d) | 2030-09-03 | common stock 200 | $1.74 | 13,088 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.14 | 2023-02-06 | deemed execution date | M | 200 (d) | 2031-04-01 | common stock 200 | $2.14 | 14,894 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.14 | 2023-02-06 | deemed execution date | M | 650 (d) | 2031-04-01 | common stock 650 | $2.14 | 45,358 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.14 | 2023-02-06 | deemed execution date | M | 750 (d) | 2031-04-01 | common stock 750 | $2.14 | 54,482 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 25.57 | 2023-02-07 | deemed execution date | A | 62,000 (a) | 2033-02-06 | common stock 62,000 | $25.57 | 62,000 | direct |
ID | footnote |
---|---|
f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on july 6, 2022. |
f2 | the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $23.84 to $24.74, inclusive. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request. |
f3 | a total of 24,108 shares subject to an employee stock option were granted on september 4, 2020, with 25% of this option vested on august 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
f4 | a total of 14,488 shares subject to an employee stock option were granted on september 4, 2020, with 25% of this option vested on june 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
f5 | a total of 16,294 shares subject to an employee stock option were granted on april 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on may 2, 2021. |
f6 | a total of 49,908 shares subject to an employee stock option were granted on april 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on july 4, 2021. |
f7 | a total of 59,732 shares subject to an employee stock option were granted on april 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on july 4, 2021. |
f8 | this option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on march 7, 2023. |